The goal of this proposal is to investigate the earliest changes during ischemia/reperfusion (I/R) injury of the heart. During the tenure of the present support, much of the research has focused on the biochemical and morphological changes during the first minutes of reoxygenation of cells (a/R) after an initial anoxic cellular event. Both the I/R heart model and isolated A/R cellular models show an initial burst of oxyradicals, along with two peaks of alkoxyl radicals, providing an experimental time-course, during which changes in lipids, proteins, enzymatic activities and morphological parameters can be sampled. The primary events producing the initial and secondary bursts of free radicals require further study. The """"""""delocalization"""""""" of iron within the cell may participate in triggering oxyradical production and propagating the subsequent free radical injury. Thus, the proposed research plan addresses the hypothesis that during the anoxia/reoxygenation process iron is released from """"""""appropriate"""""""" subcellular binding sites to other areas of the cell, where it is re-bound to """"""""ectopic"""""""" sites to trigger localized injury of lipids and proteins. The novel biochemical endpoints to be employed include: measurements of alkoxyl radicals, lipid peroxides, protein/enzyme oxidation, analyses of free iron, subcellular localization of iron (X-ray microanalysis) and peroxidation products (Meridian ACAS microscope), and phospholipase-activation. The clinically relevant goals of the proposed research are to understand the role of free radicals in the reperfusion injury process and the mechanisms by which antioxidant agents, particularly those drugs that may have immediate applications in patient therapy, are producing their protective effects.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL036418-07A1
Application #
3351433
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Project Start
1985-08-01
Project End
1997-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
7
Fiscal Year
1992
Total Cost
Indirect Cost
Name
George Washington University
Department
Type
Schools of Medicine
DUNS #
City
Washington
State
DC
Country
United States
Zip Code
20052
Mak, I Tong; Zhang, Jingyun; Weglicki, William B (2002) Protective effects of dihydropyridine Ca-blockers against endothelial cell oxidative injury due to combined nitric oxide and superoxide. Pharmacol Res 45:27-33
Dickens, Benjamin F; Weglicki, William B; Boehme, Patricia A et al. (2002) Antioxidant and lysosomotropic properties of acridine-propranolol: protection against oxidative endothelial cell injury. J Mol Cell Cardiol 34:129-37
Komarov, A M; Mak, I T; Weglicki, W B (2000) The origin of dinitrosyl-iron complex in endothelial cells. Ann N Y Acad Sci 899:407-10
Mak, I T; Komarov, A M; Kramer, J H et al. (2000) Protective mechanisms of Mg-gluconate against oxidative endothelial cytotoxicity. Cell Mol Biol (Noisy-le-grand) 46:1337-44
Mak, I T; Zhang, J; Weglicki, W B (2000) Cytoprotective properties of nisoldipine and amlodipine against oxidative endothelial cell injury. Ann N Y Acad Sci 899:403-6
Kramer, J H; Lightfoot, F G; Weglicki, W B (2000) Cardiac tissue iron: effects on post-ischemic function and free radical production, and its possible role during preconditioning. Cell Mol Biol (Noisy-le-grand) 46:1313-27
Loyevsky, M; Sacci Jr, J B; Boehme, P et al. (1999) Plasmodium falciparum and Plasmodium yoelii: effect of the iron chelation prodrug dexrazoxane on in vitro cultures. Exp Parasitol 91:105-14
Loyevsky, M; John, C; Dickens, B et al. (1999) Chelation of iron within the erythrocytic Plasmodium falciparum parasite by iron chelators. Mol Biochem Parasitol 101:43-59
Komarov, A M; Mattson, D L; Mak, I T et al. (1998) Iron attenuates nitric oxide level and iNOS expression in endotoxin-treated mice. FEBS Lett 424:253-6
Mak, I T; Dickens, B F; Komarov, A M et al. (1997) Activation of the neutrophil and loss of plasma glutathione during Mg-deficiency--modulation by nitric oxide synthase inhibition. Mol Cell Biochem 176:35-9

Showing the most recent 10 out of 60 publications